Federal health officials are reviewing a submission from Moderna seeking to have its COVID-19 shots approved for children as young as six months old.
In a series of tweets on July 5, Health Canada said they expect to make a decision by mid-July on whether or not to approve Moderna’s Spikevax COVID-19 vaccine for children between the ages of six months and five years old.
Moderna plans for two COVID shots, each one a quarter of its adult dose, to be given a month apart. If approved by Health Canada, they will be the first pharmaceutical company permitted to provide their vaccine to Canada’s youngest children….